UltraShape
UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat reduction and body contouring. The company provides clinically proven safe and effective solutions that enhance the lives of patients. UltraShape's proprietary technology uses focused ultrasound that targets and selectively disrupts fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices worldwide, demonstrating safety and efficacy of its novel technology.
Last updated on
About UltraShape
Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$15MCategory
Location
City
LivingstonState
New JerseyCountry
United StatesUltraShape
Find your buyer within UltraShape